Phase II study of combination of the hyperCVAD regimen with dasatinib in patients (pts) with newly diagnosed Philadelphia chromosome positive (Ph+) acute lymphoblastic leukemia (ALL)
暂无分享,去创建一个
H. Kantarjian | J. Cortes | F. Ravandi | G. Borthakur | S. O'brien | A. Ferrajoli | S. Faderl | R. Garris | D. Thomas | Devri L. Brown